Priority Date: 14.05.12 (US 201261646586P)

USING MODULATORS OF CCR5 FOR TREATING CANCER

  • Application ID: EP13790117
  • Status: GRANT OF PATENT INTENDED

Attorneys

operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This patent has the IPC combination A61, C12, and G01 is specialized in the combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP and 72 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 14.05.2012 - Priority Date (US 201261646586P)
  • 21.11.2013 - Publication A1 (WO2013173312)
  • 22.04.2015 - Publication A1 (EP2861302)

IPC Classification